-
1
-
-
33645523067
-
Prevalence of overweight and obesity in the United States
-
19992004
-
Ogden C L., Carroll M D., Curtin L R., McDowell M A., Tabak C J., Flegal K M. Prevalence of overweight and obesity in the United States, 19992004. JAMA 2006 295 (13) 1549-1555
-
(2006)
JAMA
, vol.295
, Issue.13
, pp. 1549-1555
-
-
Ogden, C.L.1
Carroll, M.D.2
Curtin, L.R.3
McDowell, M.A.4
Tabak, C.J.5
Flegal, K.M.6
-
2
-
-
34247851021
-
The epidemiology of obesity
-
Ogden C L., Yanovski S Z., Carroll M D., Flegal K M. The epidemiology of obesity. Gastroenterology 2007 132 (6) 2087-2102
-
(2007)
Gastroenterology
, vol.132
, Issue.6
, pp. 2087-2102
-
-
Ogden, C.L.1
Yanovski, S.Z.2
Carroll, M.D.3
Flegal, K.M.4
-
3
-
-
41649097735
-
Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: Sixteen years of follow-up in US women
-
Zhang C, Rexrode K M., van Dam R M., Li T Y., Hu F B. Abdominal obesity and the risk of all-cause, cardiovascular, and cancer mortality: sixteen years of follow-up in US women. Circulation 2008 117 (13) 1658-1667
-
(2008)
Circulation
, vol.117
, Issue.13
, pp. 1658-1667
-
-
Zhang, C.1
Rexrode, K.M.2
Van Dam, R.M.3
Li, T.Y.4
Hu, F.B.5
-
4
-
-
56249131806
-
General and abdominal adiposity and risk of death in Europe
-
Pischon T, Boeing H, Hoffmann K et al. General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008 359 (20) 2105-2120
-
(2008)
N Engl J Med
, vol.359
, Issue.20
, pp. 2105-2120
-
-
Pischon, T.1
Boeing, H.2
Hoffmann, K.3
-
5
-
-
0028917432
-
Weight gain as a risk factor for clinical diabetes mellitus in women
-
Colditz G A., Willett W C., Rotnitzky A, Manson J E. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995 122 (7) 481-486
-
(1995)
Ann Intern Med
, vol.122
, Issue.7
, pp. 481-486
-
-
Colditz, G.A.1
Willett, W.C.2
Rotnitzky, A.3
Manson, J.E.4
-
6
-
-
55849127739
-
Obesity-associated liver disease
-
Marchesini G, Moscatiello S, Di Domizio S, Forlani G. Obesity-associated liver disease. J Clin Endocrinol Metab 2008 93 (11, suppl 1) S74-S80
-
(2008)
J Clin Endocrinol Metab
, vol.93
, Issue.SUPPL 1
-
-
Marchesini, G.1
Moscatiello, S.2
Di Domizio, S.3
Forlani, G.4
-
7
-
-
37549047145
-
Fatty liver: A novel component of the metabolic syndrome
-
Kotronen A, Yki-Jrvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008 28 (1) 27-38
-
(2008)
Arterioscler Thromb Vasc Biol
, vol.28
, Issue.1
, pp. 27-38
-
-
Kotronen, A.1
Yki-Jrvinen, H.2
-
8
-
-
33845914986
-
Mechanisms linking obesity with cardiovascular disease
-
DOI 10.1038/nature05487, PII NATURE05487
-
Van Gaal L F., Mertens I L., De Block C E. Mechanisms linking obesity with cardiovascular disease. Nature 2006 444 (7121) 875-880 (Pubitemid 46028447)
-
(2006)
Nature
, vol.444
, Issue.7121
, pp. 875-880
-
-
Van Gaal, L.F.1
Mertens, I.L.2
De Block, C.E.3
-
9
-
-
19344371077
-
Visceral fat as a determinant of fibrinolysis and hemostasis
-
DOI 10.1055/s-2005-871741
-
Mertens I, Van Gaal L F. Visceral fat as a determinant of fibrinolysis and hemostasis. Semin Vasc Med 2005 5 (1) 48-55 (Pubitemid 40721045)
-
(2005)
Seminars in Vascular Medicine
, vol.5
, Issue.1
, pp. 48-55
-
-
Mertens, I.1
Van Gaal, L.F.2
-
10
-
-
44849093847
-
Abdominal obesity and the metabolic syndrome: Contribution to global cardiometabolic risk
-
Desprs J P., Lemieux I, Bergeron J et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008 28 (6) 1039-1049
-
(2008)
Arterioscler Thromb Vasc Biol
, vol.28
, Issue.6
, pp. 1039-1049
-
-
Desprs, J.P.1
Lemieux, I.2
Bergeron, J.3
-
11
-
-
38549101510
-
Hemostatic dysfunction associated with endocrine disorders as a major risk factor and cause of human morbidity and mortality: A comprehensive meta-review
-
DOI 10.1055/s-2007-1000372
-
Mina A, Favaloro E J., Koutts J. Hemostatic dysfunction associated with endocrine disorders as a major risk factor and cause of human morbidity and mortality: a comprehensive meta-review. Semin Thromb Hemost 2007 33 (8) 798-809 (Pubitemid 351158448)
-
(2007)
Seminars in Thrombosis and Hemostasis
, vol.33
, Issue.8
, pp. 798-809
-
-
Mina, A.1
Favaloro, E.J.2
Koutts, J.3
-
12
-
-
44949088433
-
Metabolic syndrome, haemostasis and thrombosis
-
DOI 10.1160/TH07-11-0682
-
Alessi M C., Juhan-Vague I. Metabolic syndrome, haemostasis and thrombosis. Thromb Haemost 2008 99 (6) 995-1000 (Pubitemid 351810479)
-
(2008)
Thrombosis and Haemostasis
, vol.99
, Issue.6
, pp. 995-1000
-
-
Alessi, M.-C.1
Juhan-Vague, I.2
-
13
-
-
70449442756
-
The metabolic syndrome as a risk factor for venous and arterial thrombosis
-
Dentali F, Squizzato A, Ageno W. The metabolic syndrome as a risk factor for venous and arterial thrombosis. Semin Thromb Hemost 2009 35 (5) 451-457
-
(2009)
Semin Thromb Hemost
, vol.35
, Issue.5
, pp. 451-457
-
-
Dentali, F.1
Squizzato, A.2
Ageno, W.3
-
14
-
-
52149093835
-
The metabolic syndrome and the risk of arterial and venous thrombosis
-
Franchini M, Targher G, Montagnana M, Lippi G. The metabolic syndrome and the risk of arterial and venous thrombosis. Thromb Res 2008 122 (6) 727-735
-
(2008)
Thromb Res
, vol.122
, Issue.6
, pp. 727-735
-
-
Franchini, M.1
Targher, G.2
Montagnana, M.3
Lippi, G.4
-
15
-
-
34248571463
-
Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease
-
DOI 10.1016/j.thromres.2006.10.005, PII S0049384806003926
-
Tavil Y, Sen N, Yazici H U., Hizal F, Abaci A, Cengel A. Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease. Thromb Res 2007 120 (2) 245-250 (Pubitemid 46759554)
-
(2007)
Thrombosis Research
, vol.120
, Issue.2
, pp. 245-250
-
-
Tavil, Y.1
Sen, N.2
Yazici, H.U.3
Hizal, F.4
Abaci, A.5
Cengel, A.6
-
16
-
-
44949092445
-
Determinants of mean platelet volume (MPV) in an elderly population: Relevance of body fat, blood glucose and ischaemic electrocardiographic changes
-
DOI 10.1160/TH07-12-0712
-
Muscari A, De Pascalis S, Cenni A et al. Determinants of mean platelet volume (MPV) in an elderly population: relevance of body fat, blood glucose and ischaemic electrocardiographic changes. Thromb Haemost 2008 99 (6) 1079-1084 (Pubitemid 351810490)
-
(2008)
Thrombosis and Haemostasis
, vol.99
, Issue.6
, pp. 1079-1084
-
-
Muscari, A.1
De Pascalis, S.2
Cenni, A.3
Ludovico, C.4
Castaldini, N.5
Antonelli, S.6
Bianchi, G.7
Magalotti, D.8
Zoli, M.9
-
17
-
-
0037164094
-
Platelet activation in obese women: Role of inflammation and oxidant stress
-
Dav G, Guagnano M T., Ciabattoni G et al. Platelet activation in obese women: role of inflammation and oxidant stress. JAMA 2002 288 (16) 2008-2014 (Pubitemid 35204691)
-
(2002)
Journal of the American Medical Association
, vol.288
, Issue.16
, pp. 2008-2014
-
-
Davi, G.1
Guagnano, M.T.2
Ciabattoni, G.3
Basili, S.4
Falco, A.5
Marinopiccoli, M.6
Nutini, M.7
Sensi, S.8
Patrono, C.9
-
18
-
-
43849092981
-
Platelet counts and platelet activation markers in obese subjects
-
ID 834153
-
Samocha-Bonet D, Justo D, Rogowski O et al. Platelet counts and platelet activation markers in obese subjects. Mediators Inflamm 2008 2008 ID 834153
-
(2008)
Mediators Inflamm
, vol.2008
-
-
Samocha-Bonet, D.1
Justo, D.2
Rogowski, O.3
-
19
-
-
40749086045
-
SP-selectin plasma levels in obesity: Association with insulin resistance and related metabolic and prothrombotic factors
-
DOI 10.1016/j.numecd.2006.09.010, PII S0939475306002109
-
De Pergola G, Pannacciulli N, C oviello M et al. sP-selectin plasma levels in obesity: association with insulin resistance and related metabolic and prothrombotic factors. Nutr Metab Cardiovasc Dis 2008 18 (3) 227-232 (Pubitemid 351384657)
-
(2008)
Nutrition, Metabolism and Cardiovascular Diseases
, vol.18
, Issue.3
, pp. 227-232
-
-
De Pergola, G.1
Pannacciulli, N.2
Coviello, M.3
Scarangella, A.4
Di Roma, P.5
Caringella, M.6
Venneri, M.T.7
Quaranta, M.8
Giorgino, R.9
-
20
-
-
40549099344
-
Effects of weight loss from a very-low-carbohydrate diet on endothelial function and markers of cardiovascular disease risk in subjects with abdominal obesity
-
Keogh J B., Brinkworth G D., Noakes M, Belobrajdic D P., Buckley J D., Clifton P M. Effects of weight loss from a very-low-carbohydrate diet on endothelial function and markers of cardiovascular disease risk in subjects with abdominal obesity. Am J Clin Nutr 2008 87 (3) 567-576 (Pubitemid 351364536)
-
(2008)
American Journal of Clinical Nutrition
, vol.87
, Issue.3
, pp. 567-576
-
-
Keogh, J.B.1
Brinkworth, G.D.2
Noakes, M.3
Belobrajdic, D.P.4
Buckley, J.D.5
Clifton, P.M.6
-
21
-
-
30744470141
-
Soluble P-selectin and CD40L levels in subjects with prediabetes, diabetes mellitus, and metabolic syndrome - The Chennai Urban Rural Epidemiology Study
-
DOI 10.1016/j.metabol.2005.08.019, PII S0026049505003410
-
Gokulakrishnan K, Deepa R, Mohan V, Gross M D. Soluble P-selectin and CD40L levels in subjects with prediabetes, diabetes mellitus, and metabolic syndromethe Chennai Urban Rural Epidemiology Study. Metabolism 2006 55 (2) 237-242 (Pubitemid 43098993)
-
(2006)
Metabolism: Clinical and Experimental
, vol.55
, Issue.2
, pp. 237-242
-
-
Gokulakrishnan, K.1
Deepa, R.2
Mohan, V.3
Gross, M.D.4
-
22
-
-
33745727432
-
The presence of metabolic syndrome is independently associated with elevated serum CD40 ligand and disease severity in patients with symptomatic coronary artery disease
-
Lee W L., Lee W J., Chen Y T. et al. The presence of metabolic syndrome is independently associated with elevated serum CD40 ligand and disease severity in patients with symptomatic coronary artery disease. Metabolism 2006 55 (8) 1029-1034
-
(2006)
Metabolism
, vol.55
, Issue.8
, pp. 1029-1034
-
-
Lee, W.L.1
Lee, W.J.2
Chen, Y.T.3
-
23
-
-
33646496156
-
Enhanced soluble CD40L in patients with the metabolic syndrome: Relationship with in vivo thrombin generation
-
Angelico F, Alessandri C, Ferro D et al. Enhanced soluble CD40L in patients with the metabolic syndrome: relationship with in vivo thrombin generation. Diabetologia 2006 49 (6) 1169-1174
-
(2006)
Diabetologia
, vol.49
, Issue.6
, pp. 1169-1174
-
-
Angelico, F.1
Alessandri, C.2
Ferro, D.3
-
24
-
-
45149117343
-
The proinflammatory mediator CD40 ligand is increased in the metabolic syndrome and modulated by adiponectin
-
DOI 10.1210/jc.2007-2491
-
Natal C, Restituto P, Iigo C, Colina I, Dez J, Varo N. The proinflammatory mediator CD40 ligand is increased in the metabolic syndrome and modulated by adiponectin. J Clin Endocrinol Metab 2008 93 (6) 2319-2327 (Pubitemid 351831554)
-
(2008)
Journal of Clinical Endocrinology and Metabolism
, vol.93
, Issue.6
, pp. 2319-2327
-
-
Natal, C.1
Restituto, P.2
Inigo, C.3
Colina, I.4
Diez, J.5
Varo, N.6
-
25
-
-
77951088791
-
In central obesity, weight loss restores platelet sensitivity to nitric oxide and prostacyclin
-
October 15 (Epub ahead of print)
-
Russo I, Traversa M, Bonomo K et al. In central obesity, weight loss restores platelet sensitivity to nitric oxide and prostacyclin. Obesity (Silver Spring) 2009 October 15 (Epub ahead of print)
-
(2009)
Obesity (Silver Spring)
-
-
Russo, I.1
Traversa, M.2
Bonomo, K.3
-
26
-
-
33750842744
-
Impact of weight reduction on production of platelet-derived microparticles and fibrinolytic parameters in obesity
-
DOI 10.1016/j.thromres.2005.12.013, PII S0049384805004949
-
Murakami T, Horigome H, Tanaka K et al. Impact of weight reduction on production of platelet-derived microparticles and fibrinolytic parameters in obesity. Thromb Res 2007 119 (1) 45-53 (Pubitemid 44716205)
-
(2007)
Thrombosis Research
, vol.119
, Issue.1
, pp. 45-53
-
-
Murakami, T.1
Horigome, H.2
Tanaka, K.3
Nakata, Y.4
Ohkawara, K.5
Katayama, Y.6
Matsui, A.7
-
29
-
-
0029983028
-
Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men
-
Cigolini M, Targher G, Bergamo Andreis I A., Tonoli M, Agostino G, De Sandre G. Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men. Arterioscler Thromb Vasc Biol 1996 16 (3) 368-374 (Pubitemid 26084311)
-
(1996)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.16
, Issue.3
, pp. 368-374
-
-
Cigolini, M.1
Targher, G.2
Andreis, I.A.B.3
Tonoli, M.4
Agostino, G.5
De Sandre, G.6
-
30
-
-
15844381594
-
Enhanced expression of PAI-1 in visceral fat: Possible contributor to vascular disease in obesity
-
DOI 10.1038/nm0796-800
-
Shimomura I, Funahashi T, Takahashi M et al. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity. Nat Med 1996 2 (7) 800-803 (Pubitemid 26225097)
-
(1996)
Nature Medicine
, vol.2
, Issue.7
, pp. 800-803
-
-
Shimomura, I.1
Funahashi, T.2
Takahashi, M.3
Maeda, K.4
Kotani, K.5
Nakamura, T.6
Yamashita, S.7
Miura, M.8
Fukuda, Y.9
Takemura, K.10
Tokunaga, K.11
Matsuzawa, Y.12
-
31
-
-
0030916877
-
Increase in both pro-thrombotic and anti-thrombotic factors in obese premenopausal women: Relationship with body fat distribution
-
De Pergola G, De Mitrio V, Giorgino F et al. Increase in both pro-thrombotic and anti-thrombotic factors in obese premenopausal women: relationship with body fat distribution. Int J Obes Relat Metab Disord 1997 21 (7) 527-535 (Pubitemid 27273497)
-
(1997)
International Journal of Obesity
, vol.21
, Issue.7
, pp. 527-535
-
-
De Pergola, G.1
De Mitrio, V.2
Giorgino, F.3
Sciaraffia, M.4
Minenna, A.5
Di Bari, L.6
Pannacciulli, N.7
Giorgino, R.8
-
32
-
-
29244436339
-
Inverse relationship between plasminogen activator inhibitor-I activity and adiponectin in overweight and obese women. Interrelationship with visceral adipose tissue, insulin resistance, HDL-chol and inflammation
-
Mertens I, Ballaux D, Funahashi T et al. Inverse relationship between plasminogen activator inhibitor-I activity and adiponectin in overweight and obese women. Interrelationship with visceral adipose tissue, insulin resistance, HDL-chol and inflammation. Thromb Haemost 2005 94 (6) 1190-1195
-
(2005)
Thromb Haemost
, vol.94
, Issue.6
, pp. 1190-1195
-
-
Mertens, I.1
Ballaux, D.2
Funahashi, T.3
-
33
-
-
25844445415
-
Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue
-
DOI 10.1111/j.1464-5491.2005.01646.x
-
Targher G, Bertolini L, Scala L, Zoppini G, Zenari L, Falezza G. Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue. Diabet Med 2005 22 (10) 1354-1358 (Pubitemid 41391311)
-
(2005)
Diabetic Medicine
, vol.22
, Issue.10
, pp. 1354-1358
-
-
Targher, G.1
Bertolini, L.2
Scala, L.3
Zoppini, G.4
Zenari, L.5
Falezza, G.6
-
34
-
-
33646061982
-
Is visceral adipose tissue a determinant of von Willebrand factor in overweight and obese premenopausal women?
-
Mertens I, Van der Planken M, Corthouts B, Van Gaal L F. Is visceral adipose tissue a determinant of von Willebrand factor in overweight and obese premenopausal women? Metabolism 2006 55 (5) 650-655
-
(2006)
Metabolism
, vol.55
, Issue.5
, pp. 650-655
-
-
Mertens, I.1
Van Der Planken, M.2
Corthouts, B.3
Van Gaal, L.F.4
-
35
-
-
33746494910
-
Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome
-
DOI 10.1038/sj.ijo.0803189, PII 0803189
-
Mertens I, Verrijken A, Michiels J J., Van der Planken M, Ruige J B., Van Gaal L F. Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome. Int J Obes (Lond) 2006 30 (8) 1308-1314 (Pubitemid 44141622)
-
(2006)
International Journal of Obesity
, vol.30
, Issue.8
, pp. 1308-1314
-
-
Mertens, I.1
Verrijken, A.2
Michiels, J.J.3
Van Der Planken, M.4
Ruige, J.B.5
Van Gaal, L.F.6
-
36
-
-
0347632946
-
Weight loss reduces tissue factor in morbidly obese patients
-
Kopp C W., Kopp H P., Steiner S et al. Weight loss reduces tissue factor in morbidly obese patients. Obes Res 2003 11 (8) 950-956 (Pubitemid 41137506)
-
(2003)
Obesity Research
, vol.11
, Issue.8
, pp. 950-956
-
-
Kopp, C.W.1
Kopp, H.-P.2
Steiner, S.3
Kriwanek, S.4
Krzyzanowska, K.5
Bartok, A.6
Roka, R.7
Minar, E.8
Schernthaner, G.9
-
37
-
-
36348983866
-
Relationship of waist and hip circumference with coagulation and fibrinolysis in postmenopausal women
-
DOI 10.1042/CS20070084
-
Peverill R E., Teede H J., Malan E, Kotsopoulos D, Smolich J J., McGrath B P. Relationship of waist and hip circumference with coagulation and fibrinolysis in postmenopausal women. Clin Sci (Lond) 2007 113 (9) 383-391 (Pubitemid 350144370)
-
(2007)
Clinical Science
, vol.113
, Issue.9-10
, pp. 383-391
-
-
Peverill, R.E.1
Teede, H.J.2
Malan, E.3
Kotsopoulos, D.4
Smolich, J.J.5
McGrath, B.P.6
-
38
-
-
0042332075
-
Associations of haemostatic variables with body mass index: A community-based study
-
DOI 10.1097/00001721-200309000-00009
-
Bowles L K., Cooper J A., Howarth D J., Miller G J., MacCallum P K. Associations of haemostatic variables with body mass index: a community-based study. Blood Coagul Fibrinolysis 2003 14 (6) 569-573 (Pubitemid 37083173)
-
(2003)
Blood Coagulation and Fibrinolysis
, vol.14
, Issue.6
, pp. 569-573
-
-
Bowles, L.K.1
Cooper, J.A.2
Howarth, D.J.3
Miller, G.J.4
MacCallum, P.K.5
-
39
-
-
0036172375
-
Insulin resistance is associated with increased circulating level of thrombin-activatable fibrinolysis inhibitor in type 2 diabetic patients
-
DOI 10.1210/jc.87.2.660
-
Hori Y, Gabazza E C., Yano Y et al. Insulin resistance is associated with increased circulating level of thrombin-activatable fibrinolysis inhibitor in type 2 diabetic patients. J Clin Endocrinol Metab 2002 87 (2) 660-665 (Pubitemid 34158234)
-
(2002)
Journal of Clinical Endocrinology and Metabolism
, vol.87
, Issue.2
, pp. 660-665
-
-
Hori, Y.1
Gabazza, E.C.2
Yano, Y.3
Katsuki, A.4
Suzuki, K.5
Adachi, Y.6
Sumida, Y.7
-
40
-
-
33748741980
-
Decrements in the thrombin activatable fibrinolysis inhibitor (TAFI) levels in association with orlistat treatment in obesity
-
Guven G S., Kiliaslan A, Oz S G. et al. Decrements in the thrombin activatable fibrinolysis inhibitor (TAFI) levels in association with orlistat treatment in obesity. Clin Appl Thromb Hemost 2006 12 (3) 364-368
-
(2006)
Clin Appl Thromb Hemost
, vol.12
, Issue.3
, pp. 364-368
-
-
Guven, G.S.1
Kiliaslan, A.2
Oz, S.G.3
-
41
-
-
0142137406
-
Weak and non-independent association between plasma TAFI antigen levels and the insulin resistance syndrome
-
Aubert H, Frre C, Aillaud M F., Morange P E., Juhan-Vague I, Alessi M C. Weak and non-independent association between plasma TAFI antigen levels and the insulin resistance syndrome. J Thromb Haemost 2003 1 (4) 791-797
-
(2003)
J Thromb Haemost
, vol.1
, Issue.4
, pp. 791-797
-
-
Aubert, H.1
Frre, C.2
Aillaud, M.F.3
Morange, P.E.4
Juhan-Vague, I.5
Alessi, M.C.6
-
42
-
-
0036123456
-
Factor XIII - Circulating levels and the Val34Leu polymorphism in the healthy male relatives of patients with severe coronary artery disease
-
Mills J D., Mansfield M W., Grant P J. Factor XIII-circulating levels and the Val34Leu polymorphism in the healthy male relatives of patients with severe coronary artery disease. Thromb Haemost 2002 87 (3) 409-414 (Pubitemid 34232480)
-
(2002)
Thrombosis and Haemostasis
, vol.87
, Issue.3
, pp. 409-414
-
-
Mills, J.D.1
Mansfield, M.W.2
Grant, P.J.3
-
43
-
-
0035512784
-
Relation between soluble adhesion molecules and insulin sensitivity in type 2 diabetic individuals: Role of adipose tissue
-
Targher G, Bonadonna R C., Alberiche M, Zenere M B., Muggeo M, Bonora E. Relation between soluble adhesion molecules and insulin sensitivity in type 2 diabetic individuals: role of adipose tissue. Diabetes Care 2001 24 (11) 1961-1966
-
(2001)
Diabetes Care
, vol.24
, Issue.11
, pp. 1961-1966
-
-
Targher, G.1
Bonadonna, R.C.2
Alberiche, M.3
Zenere, M.B.4
Muggeo, M.5
Bonora, E.6
-
44
-
-
33745168947
-
Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome
-
Arteaga R B., Chirinos J A., Soriano A O. et al. Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome. Am J Cardiol 2006 98 (1) 70-74
-
(2006)
Am J Cardiol
, vol.98
, Issue.1
, pp. 70-74
-
-
Arteaga, R.B.1
Chirinos, J.A.2
Soriano, A.O.3
-
45
-
-
0034966562
-
Plasma levels of free and total TFPI, relationship with cardiovascular risk factors and endothelial cell markers
-
Morange P E., Renucci J F., Charles M A. et al. Plasma levels of free and total TFPI, relationship with cardiovascular risk factors and endothelial cell markers. Thromb Haemost 2001 85 (6) 999-1003
-
(2001)
Thromb Haemost
, vol.85
, Issue.6
, pp. 999-1003
-
-
Morange, P.E.1
Renucci, J.F.2
Charles, M.A.3
-
46
-
-
0042332075
-
Associations of haemostatic variables with body mass index: A community-based study
-
Bowles L K., Cooper J A., Howarth D J., Miller G J., MacCallum P K. Associations of haemostatic variables with body mass index: a community-based study. Blood Coagul Fibrinolysis 2003 14 (6) 569-573
-
(2003)
Blood Coagul Fibrinolysis
, vol.14
, Issue.6
, pp. 569-573
-
-
Bowles, L.K.1
Cooper, J.A.2
Howarth, D.J.3
Miller, G.J.4
MacCallum, P.K.5
-
47
-
-
60449115830
-
Activated protein C levels in obesity and weight loss influence
-
Solá E, Navarro S, Medina P et al. Activated protein C levels in obesity and weight loss influence. Thromb Res 2009 123 (5) 697-700
-
(2009)
Thromb Res
, vol.123
, Issue.5
, pp. 697-700
-
-
Solá, E.1
Navarro, S.2
Medina, P.3
-
48
-
-
40849083460
-
Non-alcoholic fatty liver disease: The mist gradually clears
-
de Alwis N M., Day C P. Non-alcoholic fatty liver disease: the mist gradually clears. J Hepatol 2008 48 (suppl 1) S104-S112
-
(2008)
J Hepatol
, vol.48
, Issue.SUPPL 1
-
-
De Alwis, N.M.1
Day, C.P.2
-
49
-
-
67649170396
-
Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome
-
Targher G, Chonchol M, Miele L, Zoppini G, Pichiri I, Muggeo M. Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome. Semin Thromb Hemost 2009 35 (3) 277-287
-
(2009)
Semin Thromb Hemost
, vol.35
, Issue.3
, pp. 277-287
-
-
Targher, G.1
Chonchol, M.2
Miele, L.3
Zoppini, G.4
Pichiri, I.5
Muggeo, M.6
-
50
-
-
34547596738
-
High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH
-
Yoneda M, Mawatari H, Fujita K et al. High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH. J Gastroenterol 2007 42 (7) 573-582
-
(2007)
J Gastroenterol
, vol.42
, Issue.7
, pp. 573-582
-
-
Yoneda, M.1
Mawatari, H.2
Fujita, K.3
-
51
-
-
44949233003
-
Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis
-
Wieckowska A, Papouchado B G., Li Z, Lopez R, Zein N N., Feldstein A E. Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis. Am J Gastroenterol 2008 103 (6) 1372-1379
-
(2008)
Am J Gastroenterol
, vol.103
, Issue.6
, pp. 1372-1379
-
-
Wieckowska, A.1
Papouchado, B.G.2
Li, Z.3
Lopez, R.4
Zein, N.N.5
Feldstein, A.E.6
-
52
-
-
49449083979
-
Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake
-
Thuy S, Ladurner R, Volynets V et al. Nonalcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. J Nutr 2008 138 (8) 1452-1455
-
(2008)
J Nutr
, vol.138
, Issue.8
, pp. 1452-1455
-
-
Thuy, S.1
Ladurner, R.2
Volynets, V.3
-
53
-
-
44449109670
-
NASH predicts plasma inflammatory biomarkers independently of visceral fat in men
-
Targher G, Bertolini L, Rodella S et al. NASH predicts plasma inflammatory biomarkers independently of visceral fat in men. Obesity (Silver Spring) 2008 16 (6) 1394-1399
-
(2008)
Obesity (Silver Spring)
, vol.16
, Issue.6
, pp. 1394-1399
-
-
Targher, G.1
Bertolini, L.2
Rodella, S.3
-
55
-
-
35748972366
-
Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects
-
Westerbacka J, Kolak M, Kiviluoto T et al. Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects. Diabetes 2007 56 (11) 2759-2765
-
(2007)
Diabetes
, vol.56
, Issue.11
, pp. 2759-2765
-
-
Westerbacka, J.1
Kolak, M.2
Kiviluoto, T.3
-
56
-
-
34247853485
-
The adipocyte as an active participant in energy balance and metabolism
-
Badman M K., Flier J S. The adipocyte as an active participant in energy balance and metabolism. Gastroenterology 2007 132 (6) 2103-2115
-
(2007)
Gastroenterology
, vol.132
, Issue.6
, pp. 2103-2115
-
-
Badman, M.K.1
Flier, J.S.2
-
57
-
-
34247857663
-
Obesity, inflammation, and insulin resistance
-
Shoelson S E., Herrero L, Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 2007 132 (6) 2169-2180
-
(2007)
Gastroenterology
, vol.132
, Issue.6
, pp. 2169-2180
-
-
Shoelson, S.E.1
Herrero, L.2
Naaz, A.3
-
59
-
-
34047155003
-
Visceral fat adipokine secretion is associated with systemic inflammation in obese humans
-
DOI 10.2337/db06-1656
-
Fontana L, Eagon J C., Trujillo M E., Scherer P E., Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007 56 (4) 1010-1013 (Pubitemid 46525079)
-
(2007)
Diabetes
, vol.56
, Issue.4
, pp. 1010-1013
-
-
Fontana, L.1
Eagon, J.C.2
Trujillo, M.E.3
Scherer, P.E.4
Klein, S.5
-
60
-
-
43249100772
-
Visceral obesity and plasma glucose-insulin homeostasis: Contributions of interleukin-6 and tumor necrosis factor-α in men
-
DOI 10.1210/jc.2007-2191
-
Cartier A, Lemieux I, Almras N, Tremblay A, Bergeron J, Desprs J P. Visceral obesity and plasma glucose-insulin homeostasis: contributions of interleukin-6 and tumor necrosis factor-alpha in men. J Clin Endocrinol Metab 2008 93 (5) 1931-1938 (Pubitemid 351656540)
-
(2008)
Journal of Clinical Endocrinology and Metabolism
, vol.93
, Issue.5
, pp. 1931-1938
-
-
Cartier, A.1
Lemieux, I.2
Almeras, N.3
Tremblay, A.4
Bergeron, J.5
Despres, J.-P.6
-
61
-
-
4544335155
-
Hepatocyte apoptosis, expression of death receptors, and activation of NF-κB in the liver of nonalcoholic and alcoholic steatohepatitis patients
-
DOI 10.1111/j.1572-0241.2004.40009.x
-
Ribeiro P S., Cortez-Pinto H, Solá S et al. Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients. Am J Gastroenterol 2004 99 (9) 1708-1717 (Pubitemid 39237497)
-
(2004)
American Journal of Gastroenterology
, vol.99
, Issue.9
, pp. 1708-1717
-
-
Ribeiro, P.S.1
Cortez-Pinto, H.2
Sola, S.3
Castro, R.E.4
Ramalho, R.M.5
Baptista, A.6
Moura, M.C.7
Camilo, M.E.8
Rodrigues, C.M.P.9
-
62
-
-
34547558619
-
Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity
-
DOI 10.2337/db07-0111
-
Kolak M, Westerbacka J, Velagapudi V R. et al. Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity. Diabetes 2007 56 (8) 1960-1968 (Pubitemid 47195815)
-
(2007)
Diabetes
, vol.56
, Issue.8
, pp. 1960-1968
-
-
Kolak, M.1
Westerbacka, J.2
Velagapudi, V.R.3
Wagsater, D.4
Yetukuri, L.5
Makkonen, J.6
Rissanen, A.7
Hakkinen, A.-M.8
Lindell, M.9
Bergholm, R.10
Hamsten, A.11
Eriksson, P.12
Fisher, R.M.13
Oresic, M.14
Yki-Jarvinen, H.15
-
63
-
-
0034676629
-
Cytokines in alcoholic and nonalcoholic steatohepatitis
-
Tilg H, Diehl A M. Cytokines in alcoholic and nonalcoholic steatohepatitis. N Engl J Med 2000 343 (20) 1467-1476
-
(2000)
N Engl J Med
, vol.343
, Issue.20
, pp. 1467-1476
-
-
Tilg, H.1
Diehl, A.M.2
-
64
-
-
39149104311
-
Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis
-
Marra F, Gastaldelli A, Svegliati Baroni G, Tell G, Tiribelli C. Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends Mol Med 2008 14 (2) 72-81
-
(2008)
Trends Mol Med
, vol.14
, Issue.2
, pp. 72-81
-
-
Marra, F.1
Gastaldelli, A.2
Svegliati Baroni, G.3
Tell, G.4
Tiribelli, C.5
-
65
-
-
53549112749
-
Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: Causal effect or epiphenomenon?
-
Targher G, Marra F, Marchesini G. Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon? Diabetologia 2008 51 (11) 1947-1953
-
(2008)
Diabetologia
, vol.51
, Issue.11
, pp. 1947-1953
-
-
Targher, G.1
Marra, F.2
Marchesini, G.3
-
66
-
-
0036144672
-
Stromal cells are the main plasminogen activator inhibitor-1 - Producing cells in human fat: Evidence of differences between visceral and subcutaneous deposits
-
DOI 10.1161/hq0102.101552
-
Bastelica D, Morange P, Berthet B et al. Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat: evidence of differences between visceral and subcutaneous deposits. Arterioscler Thromb Vasc Biol 2002 22 (1) 173-178 (Pubitemid 34076250)
-
(2002)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.22
, Issue.1
, pp. 173-178
-
-
Bastelica, D.1
Morange, P.2
Berthet, B.3
Borghi, H.4
Lacroix, O.5
Grino, M.6
Juhan-Vague, I.7
Alessi, M.-C.8
-
67
-
-
0037962069
-
Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation
-
Alessi M C., Bastelica D, Mavri A et al. Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation. Arterioscler Thromb Vasc Biol 2003 23 (7) 1262-1268
-
(2003)
Arterioscler Thromb Vasc Biol
, vol.23
, Issue.7
, pp. 1262-1268
-
-
Alessi, M.C.1
Bastelica, D.2
Mavri, A.3
|